‘Enough capacity to meet hydroxychloroquine demand’

Indian pharma industry on Tuesday said there is enough stock of hydroxychloroquine in the country, and drug firms are ready to ramp up the production to meet domestic as well as export requirements. India has decided to partially lift the ban on the export of anti-malarial drug hydroxychloroquine in sync with its global commitment to deal with coronavirus pandemic.

Leave a Reply

Your email address will not be published. Required fields are marked *